l o a d i n g
:::

字級:

:::
首頁 > 團隊介紹 > 陳志根 醫生資料

陳志根

醫師

1.精神藥理學 2.生物精神醫學 3.精神科流行病學 4.成癮物質相關疾患學

醫生資料

現職

  • 基隆長庚紀念醫院臨床試驗中心主任
  • 基隆長庚紀念醫院精神科教授級主治醫師
  • 長庚大學醫學院教授
  • 台灣生物精神醫學暨神經精神藥理學學會理事

經歷

  • 基隆長庚醫院精神科主任

學歷

  • 英國倫敦大學精神醫學博士
  • 陽明大學醫學院醫學士

語言

  • 國語,英語,閩南語

教職

  • 教授

學會與認證

  • 精神科專科醫師
  • 成癮次專科醫師
  • 台灣生物精神醫學暨神經精神藥理學學會監事

論文及期刊發表

  • Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users.
  • Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users.
  • Predictors of Relapse and Dropout During a 12-week Relapse Prevention Program for Methamphetamine Users.
  • Is case management effective for long-lasting suicide prevention?
  • Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
  • Neurocognitive Performance and Behavioral Symptoms in Patients with Attention-Deficit/Hyperactivity Disorder During Twenty-Four Months of Treatment with Methylphenidate.
  • Switching suicide methods as a predictor of completed suicide in individuals with repeated self-harm: A community cohort study in northern Taiwan.
  • A Roller Coaster from Methamphetamine to Ketamine.
  • Prescription of psychotropic drugs in patients with chronic renal failure on hemodialysis.
  • Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study.
  • The association of uremic toxins and inflammation in hemodialysis patients.
  • Is suicide mortality associated with meteorological and socio-economic factors? An ecological study in a city in Taiwan with a high suicide rate.
  • A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior.
  • Methods of suicide predict the risks and method-switching of subsequent suicide attempts: a community cohort study in Taiwan.
  • Polymorphisms of COMT Val158Met and DAT1 3'-UTR VNTR in Illicit Drug Use and Drug-Related Psychiatric Disorders. Subst Use Misuse.
  • Depression, 5HTTLPR and BDNF Val66Met polymorphisms, and plasma BDNF levels in hemodialysis patients with chronic renal failure.
  • Taiwan Bipolar Consortium Variant GADL1 and response to lithium therapy in bipolar I disorder.
  • Health care service utilization and associated factors among heroin users in northern Taiwan.
  • Association of brain serotonin transporter availability and brain-derived neurotrophic factor in models of serotonin transporter genotypes in healthy subjects.
  • Neurocognitive effects of aripiprazole in adolescents and young adults with schizophrenia.
  • Changes in Behaviour Symptoms of Patients with Attention-Deficit/Hyperactivity Disorder during Treatment: Observation from Different Informants.
  • Investigation of the ZNF804A gene polymorphism with genetic risk for bipolar disorder in attention deficit hyperactivity disorder.
  • Adjunctive effects of aripiprazole on metabolic profiles: Comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.
  • Risk Factors for HIV, Viral Hepatitis, and Syphilis among Heroin Users in Northern Taiwan.
  • Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.
  • The Trend in Morning Levels of Salivary Cortisol in Children with ADHD during 6 Months of Methylphenidate Treatment.
  • Low plasma dehydroepiandrosterone sulfate increases mortality risk among male hemodialysis patients: A prospective cohort study.
  • The relationship between psychological factors, inflammation, and nutrition in patients with chronic renal failure undergoing hemodialysis.
  • Impaired cognition in bipolar I disorder: The roles of the serotonin transporter and brain-derived neurotrophic factor.
  • Long-term neurocognitive effects of methylphenidate in patients with Attention Deficit Hyperactivity Disorder, even at drug-free status.
  • Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study.
  • Factors Associated with Drug-related Psychiatric Disorders and Suicide Attempts among Illicit Drug Users in Taiwan.
  • Effectiveness of aripiprazole in adolescents and young adults with schizophrenia spectrum disorders: Comparison of first-episode to recurrent psychosis.
  • Neurocognitive effects of aripiprazole in adolescents and young adults with bipolar disorder.
  • Workplace Sexual Harassment in Two General Hospitals in Taiwan: The Incidence, Perception, and Gender Differences.
  • Active Job, Healthy Job? Occupational Stress and Depression among Hospital Physicians in Taiwan.
  • Aripiprazole and dehydroaripiprazole plasma concentrations and clinical response in patients with schizophrenia.
  • A COMT gene haplotype associated with methamphetamine abuse.
  • Rapid initiation of quetiapine well tolerated as compared with the conventional initiation regimen in patients with schizophrenia or schizoaffective disorders.
  • Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate.
  • Genome-wide association study of bipolar I disorder in the Han Chinese population.
  • Clinical symptoms and performance on the continuous performance test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months.
  • Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder.
  • A Double-blind, Randomized, Comparative Study to Evaluate the Efficacy and Safety of Zaleplon versus Zolpidem in Shortening Sleep Latency in Primary Insomnia.
  • Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
  • Depression and Suicide Risk for Hemodialysis Patients with Chronic Renal Failure.
  • Long-term effectiveness of aripiprazole in adolescents and young adults with bipolar disorder: a naturalistic study.
  • Association study between a polymorphism at the 3'-untranslated region of CLOCK gene and attention deficit hyperactivity disorder.
  • Lack of association between plasma Dehydroepiandrosterone Sulfate (DHEA-S) levels and depression in hemodialysis patients: A cross-sectional study.
  • Clinical Effectiveness of Group Cognitive-behavioral Therapy for Primary and Secondary Insomnia.
  • Clinical characteristics, precipitating stressors, and correlates of lethality among suicide attempters.
  • Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole.
  • Courses of aripiprazole- associated tardive dyskinesia: report of two cases.
  • Lower Prevalence of Depression in Hemodialysis Patients Who Use Polysulfone Dialyzers.
  • Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder; a 12-month follow-up.
  • Association study of promoter polymorphisms at the dopamine transporter gene in attention deficit hyperactivity disorder.
  • Genome-wide association for methamphetamine dependence: convergent results from 2 samples.